The Weekly Roundup: July 3-8

Hot Topics at the SPD 2022 47th Annual Meeting

From pediatric dermatology quizzes to the latest news in telederm to practical pearls on atopic dermatitis, alopecia, and vitiligo, there’s a lot going on at the SPD 2022 47th Annual Meeting, this year in Indianapolis, Indiana.

Poster Sessions at the SPD 2022 47th Annual Meeting

An extraordinary display of posters at this year's Society for Pediatric Dermatology Meeting in Indianapolis, Indiana.

The Mainstream Patient: July 4

This week's edition of the Mainstream Patient features stories about abortions, spray sunscreen, tinted moisturizers, and more.

POLL: How Often Does Skin Renew Itself?

Click here to answer this week's poll.

Dermatological Conditions and the Relationship to Self-Image

It is important for pediatric and family nurse practitioners caring for patients with dermatological conditions to be comfortable talking about the conditions with children, adolescents, and their parents.

FDA Issues Third CRL in 2 years to Verrica Pharmaceuticals

Verrica is complying with the FDA through 3 Complete Response Letters to achieve the first FDA-approved treatment of molluscum contagiosum.

Consider Mental Health Concerns in Teens With Acne

The effect of acne is more than skin deep.

How Dupixent Improves Moderate-to-Severe AD in Adult and Pediatric Patients

Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the Maui Derm NP+PA 2022 Summer Conference in Colorado Springs, Colorado.

How Personalized Medicine Has the Potential to Revolutionize Dermatology

Recent advances in technology have begun to allow the realization of personalized medicine in the practice of dermatology.

Bernard Cohen, MD, Shares his Favorite sessions at the Society for Pediatric Dermatology Meeting

Bernard A. Cohen, MD, shares what he thinks will be most exciting at this year's Society for Pediatric Dermatology Meeting in Indianapolis, Indiana.

Burden of atopic dermatitis in infants/preschoolers from EPI-CARE: an international study

At the SPD 2022 47th Annual Meeting in Indianapolis, Indiana, a poster session on atopic dermatitis severity and outcomes in young children from 5 regions around the world.

Dupilumab Treatment Improves Sleep Quality in Moderate-to-Severe AD in Children and Their Caregivers

Sleep disturbance is a significant factor in reduced quality of life for children and adolescents. A study at the SPD 2022 47th Annual Meeting on treating this population with dupilumab (Dupixent) to help with sleep quality showed positive results.

Atopic Dermatitis in Pediatric Patients With Skin of Color-Perspectives

At the SPD 2022 47th Annual Meeting in Indianapolis, Candrice R. Heath, MD, FAAP, FAAD share compelling best practices for treating patients of color with this condition.